News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Celera Genomics Group-an Applera Corp. Business (CRA) Grants Real Time PCR License to Siemens Medical Solutions Diagnostics (Berkeley, CA) (SI)


10/1/2007 10:15:29 AM

ROCKVILLE, Md. & ALAMEDA, Calif.--(BUSINESS WIRE)--Celera (NYSE:CRA), an Applera Corporation business, announced today that it has entered into agreements with Siemens Medical Solutions Diagnostics which include a license conferring rights in the human in vitro diagnostics field to the Applera patents for real time PCR thermalcycling instruments and reagents. The financial details of these agreements were not disclosed.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES